The Scientist

» retractions and disease/medicine

Most Recent

image: Second Contagious Cancer Found in Tasmanian Devils

Second Contagious Cancer Found in Tasmanian Devils

By | December 29, 2015

A second fatal, transmissible cancer has been identified in the already endangered species.  

0 Comments

image: The Top 10 Retractions of 2015

The Top 10 Retractions of 2015

By | December 23, 2015

A look at this year’s most memorable retractions

2 Comments

image: Year in Review: Hot Topics

Year in Review: Hot Topics

By | December 21, 2015

In 2015, The Scientist dove deep into the latest research on aging, HIV, hearing, and obesity.

0 Comments

image: When the Flu Vax Fails

When the Flu Vax Fails

By | December 16, 2015

The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 

0 Comments

image: Global Food-Related Disease Estimate

Global Food-Related Disease Estimate

By | December 7, 2015

More than 400,000 people—including 125,000 children—die from foodborne illness every year, according to the World Health Organization.

0 Comments

image: Family Ties

Family Ties

By | December 1, 2015

There’s more to inheritance than genes.

3 Comments

image: The Regenerator

The Regenerator

By | December 1, 2015

In his search for effective therapies for Parkinson’s disease, Lorenz Studer is uncovering pluripotency switches and clues to what makes cells age.

0 Comments

image: BRCA1 Linked to Alzheimer’s

BRCA1 Linked to Alzheimer’s

By | November 30, 2015

The cancer-related protein BRCA1 is important for learning and memory in mice and is depleted in the brains of Alzheimer’s patients, according to a study.

0 Comments

image: Cortical Census

Cortical Census

By | November 26, 2015

Scientists document the characteristics and connections of mouse neocortical neurons to establish the most detailed microcircuit map to date.

1 Comment

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS